BIO-PATH HOLDINGS, Inc. (BPTH) intrinsic value & 10-year financials
BIO-PATH HOLDINGS, Inc. (BPTH) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.00
- Market cap
- $720
- Revenue (FY2024)
- —
- Revenue growth (10-yr CAGR)
- 184.6%
- ROIC (10-yr avg)
- -794.1%
- Free cash flow (FY2024)
- —
BPTH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2024 | — | -$9.9M | -$4.12 | — | — | 1995.3% |
| FY2023 | — | -$16.1M | -$6.73 | — | — | -959.6% |
| FY2022 | — | -$13.9M | -$0.38 | -$15.1M | — | -484.4% |
| FY2021 | — | -$10.4M | -$0.31 | -$10.0M | — | -616.7% |
| FY2020 | — | -$10.9M | -$0.57 | — | — | -858.6% |
| FY2019 | — | -$8.6M | — | -$8.4M | — | -1444.0% |
| FY2018 | $0 | -$8.6M | — | -$6.1M | — | -4014.0% |
| FY2017 | $37.0K | -$7.0M | — | -$8.5M | -24232.4% | -110.0% |
| FY2016 | $13.0K | -$6.8M | — | -$8.5M | -65192.3% | -879.8% |
| FY2015 | $0 | -$5.5M | — | -$5.0M | — | -569.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BIO-PATH HOLDINGS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
BIO-PATH HOLDINGS, INC. has historically struggled to out-earn its cost of capital, averaging just -18.8% ROIC.
BIO-PATH HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BIO-PATH HOLDINGS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-136.85 per share.